directmeds tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity DirectMeds vs MedVi 2026: GLP-1

It is specifically approved for adults with obesity (BMI 30) or adults who are overweight (BMI 27) and have at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol

For example, if you normally inject on Tuesday, moving to Wednesday or Thursday is generally safe and allows your provider to adjust your future schedule

Clear and radiant skin frequently boosts: Self-confidence Professional presence Social comfort Overall emotional well-being For many individuals, investing in advanced skincare is an empowering step toward personal and professional growth

adjusted HR, 1.79

Uterine Artery Embolization for Symptomatic Uterine Fibroids